As part of Translational Development in Oxford Nanopore Technologies, Alex works on prototyping and developing clinical applications of nanopore technology in the infection space. His background is in infection diagnostics and his PhD was on the application of nanopore sequencing to the rapid identification of prosthetic joint infection through metagenomics. Following that, Alex worked as part of the COVID-19 Genomics UK Consortium (COG-UK) using sequencing to track SARS-CoV2 variants at the Quadram Institute in Norwich, before moving to Oxford Nanopore.